Anesthetic considerations for valve replacement surgery in a patient with carcinoid syndrome.
Propst
J W
JW
Department of Anesthesia, Stanford University School of Medicine, CA 94305-5117.
Siegel
L C
LC
Stover
E P
EP
D000771:Anesthesia, Intravenous; D007611:Aprotinin / Q000008:administration & dosage / Q000627:therapeutic use; D001705:Bioprosthesis; D002275:Carcinoid Heart Disease / Q000000981:diagnostic imaging / Q000601:surgery*; D017548:Echocardiography, Transesophageal; D005260:Female; D005283:Fentanyl; D006350:Heart Valve Prosthesis; D006801:Humans; D008303:Malignant Carcinoid Syndrome / Q000503:physiopathology; D008874:Midazolam; D008875:Middle Aged; D015282:Octreotide / Q000008:administration & dosage / Q000627:therapeutic use; D011664:Pulmonary Valve / Q000000981:diagnostic imaging / Q000601:surgery*; D014261:Tricuspid Valve / Q000000981:diagnostic imaging / Q000601:surgery*; D018084:Ultrasonography, Interventional
D007611:Aprotinin; D008874:Midazolam; D015282:Octreotide; D005283:Fentanyl